ScholarIQanswers from OpenAlex

STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells

PaperCitations, authors & open-access status

STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells is a paper indexed in ScholarIQ from OpenAlex.

How many citations does STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells have?

ScholarIQcitation count

STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells has 431 citations in the OpenAlex counts ScholarIQ stores.

When was STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells published?

ScholarIQyear

STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells has 2005 year in the ScholarIQ index.

What is the open-access status of STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells?

ScholarIQoa status

STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells has closed oa status in the ScholarIQ index.

What is the DOI of STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells?

ScholarIQdoi

The DOI for STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells is on the source record.

What is the PMID of STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells?

ScholarIQpmid

The PMID for STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells is on the source record.

What is the OpenAlex record for STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells?

ScholarIQopenalex

The OpenAlex for STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial